KALOS and LOGOS trials with 4,400 patients showed Breztri improved lung function over dual ICS/LABA therapies. No new safety concerns were found in Breztri Phase 3 asthma trials; all primary endpoints were met.

LOS ANGELES, May 02, 2025 ( GLOBE NEWSWIRE ) -- What makes Mitolyn's formula unique, and how does it support long-term weight management through mitochondrial health The real story behind Mitolyn's complaints, Reddit threads, and fake review warnings flooding the internet in 2025

Cook said Apple expects a $900 million cost impact in the June quarter due to tariffs. Today's manic market swings are creating the perfect setup for Matt's next volatility trade. Get his next trade alert for free, right here. Apple Inc.

U.S.-listed Chinese stocks and EV companies surge as Beijing considers talks with the U.S. on tariff reductions. Alibaba, PDD, Baidu, and Chinese EVs gain traction, fueled by potential tariff relief amid geopolitical tensions. Today's manic market swings are creating the perfect setup for Matt's ...

Snap shares have dropped 13% since Tuesday's session. The company delivered better-than-expected Q1 earnings. Learn the top momentum trading strategies for today's whipsaw market, live with Chris Capre on Sunday, May 4 at 1 PM ET. Reserve your free spot now.

As Ether's price has struggled in the first quarter of 2025, a US-based investment adviser firm, Two Prime, has dropped support for ETH and adopted a Bitcoin-only strategy.After lending $1.5 billion in loans both in Bitcoin ( BTC ) and Ether ( ETH ) over the past 15 months, Two Prime decided to ...

Starbucks Corp SBUX shares experienced a sharp midweek decline of nearly 10%, falling to $76.37 after the company reported disappointing fiscal second-quarter results.

Average fees for active funds are seven times higher than trackers ...

U.S. stocks were higher, with the Dow Jones index gaining around 400 points on Friday. Shares of Trupanion, Inc. TRUP rose sharply during Friday's session after the company reported better-than-expected first-quarter financial results and raised its FY25 sales guidance.

Cinemark posted a wider-than-expected Q1 loss of $0.32 per share, though revenue slightly beat estimates at $540.7 million. Despite lower earnings and attendance, Cinemark outperformed industry box office benchmarks both domestically and internationally. Feel unsure about the market's next move?